A detailed history of Voya Investment Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Voya Investment Management LLC holds 51,583 shares of EXAS stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,583
Previous 113,733 54.65%
Holding current value
$2.18 Million
Previous $8.41 Million 57.66%
% of portfolio
0.0%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $3.5 Million - $4.58 Million
-62,150 Reduced 54.65%
51,583 $3.56 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $4.04 Million - $5.18 Million
68,363 Added 150.68%
113,733 $8.41 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $1.3 Million - $1.95 Million
-19,642 Reduced 30.21%
45,370 $3.1 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $2.13 Million - $3.23 Million
34,000 Added 109.63%
65,012 $6.1 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $28,833 - $43,240
-611 Reduced 1.93%
31,012 $2.1 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $5,554 - $9,726
-183 Reduced 0.58%
31,623 $1.57 Million
Q3 2022

Mar 03, 2023

BUY
$31.97 - $49.37 $5,850 - $9,034
183 Added 0.58%
31,806 $1.03 Million
Q3 2022

Nov 14, 2022

SELL
$31.97 - $49.37 $22,730 - $35,102
-711 Reduced 2.19%
31,806 $1.03 Million
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $1.67 Million - $3.58 Million
-46,990 Reduced 59.1%
32,517 $1.28 Million
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $28,434 - $40,774
-494 Reduced 0.62%
79,507 $5.56 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $2.03 Million - $2.82 Million
28,058 Added 54.02%
80,001 $6.23 Million
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $39.8 Million - $54.8 Million
-441,524 Reduced 89.47%
51,943 $4.96 Million
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $137 Million - $203 Million
-1,458,202 Reduced 74.72%
493,467 $61.3 Million
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $3.41 Million - $4.53 Million
29,214 Added 1.52%
1,951,669 $257 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $99.9 Million - $143 Million
1,002,791 Added 109.04%
1,922,455 $255 Million
Q3 2020

Nov 16, 2020

BUY
$72.92 - $102.01 $22.1 Million - $31 Million
303,523 Added 49.26%
919,664 $93.8 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $13 Million - $21.6 Million
233,152 Added 60.88%
616,141 $53.6 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $7.94 Million - $21.9 Million
-209,603 Reduced 35.37%
382,989 $22.2 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $26.4 Million - $33.9 Million
339,973 Added 134.58%
592,592 $54.8 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $17 Million - $23 Million
-187,582 Reduced 42.61%
252,619 $22.8 Million
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $22.5 Million - $29.7 Million
-251,819 Reduced 36.39%
440,201 $52 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $19.6 Million - $30.5 Million
-316,527 Reduced 31.38%
692,020 $59.9 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $5.81 Million - $8.57 Million
-103,688 Reduced 9.32%
1,008,547 $63.6 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $46.6 Million - $77.8 Million
965,760 Added 659.33%
1,112,235 $87.8 Million
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $16.8 Million - $31 Million
-443,417 Reduced 75.17%
146,475 $8.76 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $41.4 Million - $59.7 Million
-1,038,441 Reduced 63.77%
589,892 $23.8 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $23.5 Million - $30.6 Million
-505,028 Reduced 23.67%
1,628,333 $85.6 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $79 Million - $101 Million
2,133,361
2,133,361 $101 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.48B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.